US Food and Drug Administration regulatory updates in neuro-oncology.

Gautam U MehtaAmy K BaroneDiana BradfordErin LarkinsJanice KimLee Pai-ScherfAdnan JaigirdarMirat ShahSuparna WedamLaleh Amiri-KordestaniMarc R TheoretRichard PazdurJulia A BeaverHarpreet Singh

Published in: Journal of neuro-oncology (2021)

Despite the challenges of the past year brought on by the COVID-19 pandemic, progress continues to be made in neuro-oncology. These include first-of-their-kind FDA approvals and Guidances that are relevant to the management of patients with nervous system tumors.

Keyphrases

drug administration
palliative care
transcription factor
human health
risk assessment
climate change